{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:38:21Z","timestamp":1788899901253,"version":"build-2803163510"},"reference-count":40,"publisher":"Medknow","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/jcrt.jcrt_56_17","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:56:03Z","timestamp":1505282163000},"page":"613","source":"Crossref","is-referenced-by-count":8,"title":["The clinical application of HPV E6\/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: A meta-analysis"],"prefix":"10.4103","volume":"13","author":[{"given":"Chenchen","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0973-1482.214479-1","first-page":"CD009836","volume-title":"Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0973-1482.214479-2","first-page":"283","volume-title":"Diagnostic value of combination of HPV testing and cytology as compared to isolated cytology in screening cervical cancer: A meta-analysis","author":"Li","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"key-10.4103\/0973-1482.214479-3","first-page":"S36","volume-title":"Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.4103\/0973-1482.214479-4","first-page":"S43","volume-title":"Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"key-10.4103\/0973-1482.214479-5","first-page":"S3\/78","volume-title":"Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"key-10.4103\/0973-1482.214479-6","first-page":"F88","volume-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"key-10.4103\/0973-1482.214479-7","first-page":"K29","volume-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"key-10.4103\/0973-1482.214479-8","first-page":"342","volume-title":"European guidelines for quality assurance in cervical cancer screening: Recommendations for clinical management of abnormal cervical cytology, part 1","author":"Jordan","year":"2008","journal-title":"Cytopathology"},{"key":"key-10.4103\/0973-1482.214479-9","first-page":"1867","volume-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: The Predictors 2 study","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0973-1482.214479-10","first-page":"5","volume-title":"Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions","author":"Alanen","year":"1998","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.214479-11","first-page":"8501","volume-title":"Activation of p53 in cervical carcinoma cells by small molecules","author":"Hietanen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0973-1482.214479-12","first-page":"4417","volume-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes","author":"M\u00fcnger","year":"1989","journal-title":"J Virol"},{"key":"key-10.4103\/0973-1482.214479-13","first-page":"533","volume-title":"E6\/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2\/CIN3): A promising perspective","author":"Origoni","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"key-10.4103\/0973-1482.214479-14","first-page":"65","volume-title":"Human papillomavirus type specific DNA and RNA persistence \u2013 Implications for cervical disease progression and monitoring","author":"Cuschieri","year":"2004","journal-title":"J Med Virol"},{"key":"key-10.4103\/0973-1482.214479-15","first-page":"2536","volume-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/0973-1482.214479-16","first-page":"525","volume-title":"Molecular biology of human papillomavirus infection and cervical cancer","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"key-10.4103\/0973-1482.214479-17","first-page":"691","volume-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0973-1482.214479-18","first-page":"S55","volume-title":"Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"key-10.4103\/0973-1482.214479-19","first-page":"2390","volume-title":"High-risk human papillomavirus (hrHPV) E6\/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology","author":"Rijkaart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0973-1482.214479-20","first-page":"e90023","volume-title":"Triage of HR-HPV positive women with minor cytological abnormalities: A comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study","author":"Persson","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214479-21","first-page":"389","volume-title":"Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)","author":"Waldstrom","year":"2012","journal-title":"Cytopathology"},{"key":"key-10.4103\/0973-1482.214479-22","first-page":"e0124460","volume-title":"Presence of high-risk HPV mRNA in relation to future high-grade lesions among high-risk HPV DNA positive women with minor cytological abnormalities","author":"Johansson","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214479-23","first-page":"1052","volume-title":"Clinical performance of a human papillomavirus messenger RNA test (Aptima HPV Assay) on residual material from archived 3-year-old PreservCyt samples with low-grade squamous intraepithelial lesion","author":"Waldstr\u00f8m","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/0973-1482.214479-24","first-page":"973","volume-title":"Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear","author":"Molden","year":"2005","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0973-1482.214479-25","first-page":"457","volume-title":"Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6\/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: Diagnostic and prognostic implications","author":"Varnai","year":"2008","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0973-1482.214479-26","first-page":"473","volume-title":", Stoler MH, Cuzick J, Castle PE, Dockter J, et al. Human papillomavirus oncogenic mRNA testing for cervical cancer screening: Baseline and longitudinal results from the CLEAR study","author":"Reid","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/0973-1482.214479-27","first-page":"e26022","volume-title":"HPV E6\/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy","author":"S\u00f8rbye","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214479-28","first-page":"e57600","volume-title":"Prognostic value of HPV E6\/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: A follow-up study","author":"Giorgi","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214479-29","first-page":"15","volume-title":"Prognostic value of DNA and mRNA e6\/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2","author":"Discacciati","year":"2014","journal-title":"Biomark Insights"},{"key":"key-10.4103\/0973-1482.214479-30","first-page":"869","volume-title":"Diagnostic and prognostic validity of the human papillomavirus E6\/E7 mRNA test in cervical cytological samples of HC2-positive patients","author":"Benevolo","year":"2011","journal-title":"Cancer Causes Control"},{"key":"key-10.4103\/0973-1482.214479-31","first-page":"461","volume-title":"Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age","author":"Frega","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key-10.4103\/0973-1482.214479-32","first-page":"1242","volume-title":"Prospective evaluation of E6\/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol","author":"Padalko","year":"2013","journal-title":"J Med Virol"},{"key":"key-10.4103\/0973-1482.214479-33","first-page":"1063","volume-title":"Human papillomavirus (HPV) E6\/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA","author":"Perez","year":"2013","journal-title":"J Med Virol"},{"key":"key-10.4103\/0973-1482.214479-34","first-page":"278","volume-title":"Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS\/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3","author":"Ovestad","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/0973-1482.214479-35","first-page":"1927","volume-title":"Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds","author":"Trop\u00e9","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0973-1482.214479-36","first-page":"1864","volume-title":"Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark","author":"Kjaer","year":"2008","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0973-1482.214479-37","first-page":"1582","volume-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0973-1482.214479-38","first-page":"1831","volume-title":"Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"key-10.4103\/0973-1482.214479-39","first-page":"101","volume-title":"The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy","author":"Arbyn","year":"2013","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0973-1482.214479-40","first-page":"908","volume-title":"DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia","author":"Lie","year":"2005","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:56:25Z","timestamp":1505282185000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cancerjournal.net\/text.asp?2017\/13\/4\/613\/214479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["214479"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_56_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}